Clearside

CLSD NASDAQ
1.030
-0.010
-0.96%
已收盘, 16:25 06/17 EDT
开盘
1.050
昨收
1.040
最高
1.070
最低
1.020
成交量
21.26万
成交均量(3M)
42.25万
52周最高
11.25
52周最低
0.9500
换手率
0.57%
市值
3,872.34万
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Clearside CLSD股票价格,Clearside股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Clearside Biomedical, Inc. is a clinical biopharmaceutical company developing first-in-class drug therapies to treat blinding diseases of the eye. The Company's product candidates focus on diseases affecting the retina, which is the tissue that lines the inside of the eye and is primarily responsible for vision, and the choroid, which is the layer adjacent to the retina that supplies the retina with blood, oxygen and nourishment. With its microinjector, drugs are injected into and spread within and through the suprachoroidal space, (SCS), which is the space located between the choroid and the outer protective layer of the eye known as the sclera. With the suprachoroidal injection, its product candidates are more directly administered to the retina and choroid as compared to other ocular drug administration techniques, such as injections of drug into the vitreous, a jelly-like substance that occupies the central portion of the eye.
展开 >

最近浏览

名称
价格
涨跌幅